CLOS
Compagnie Lombard Odier SCmA Portfolio holdings
AUM
$7.58B
This Quarter Return
-11.56%
1 Year Return
+23.11%
3 Year Return
+107.08%
5 Year Return
+161.87%
10 Year Return
+392.97%
AUM
$2.44B
AUM Growth
+$2.44B
(-15%)
Cap. Flow
-$34.9M
Cap. Flow
% of AUM
-1.43%
Top 10 Holdings %
Top 10 Hldgs %
35.71%
Holding
625
New
67
Increased
114
Reduced
137
Closed
68
Top Buys
| 1 |
Linde
LIN
|
$38.7M |
| 2 |
iShares 10-20 Year Treasury Bond ETF
TLH
|
$28.8M |
| 3 |
Thermo Fisher Scientific
TMO
|
$25.1M |
| 4 |
Vanguard Long-Term Treasury ETF
VGLT
|
$17.3M |
| 5 |
Spotify
SPOT
|
$13.7M |
Top Sells
| 1 |
DexCom
DXCM
|
$54M |
| 2 |
Live Nation Entertainment
LYV
|
$14.9M |
| 3 |
Alibaba
BABA
|
$14.2M |
| 4 |
AbbVie
ABBV
|
$12.2M |
| 5 |
Mondelez International
MDLZ
|
$11.9M |
Sector Composition
| 1 | Communication Services | 15.26% |
| 2 | Financials | 14.4% |
| 3 | Healthcare | 14.37% |
| 4 | Technology | 12.53% |
| 5 | Consumer Discretionary | 11.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
601
CRISPR Therapeutics
CRSP
$4.82B
| – | – |
-800
| Closed | -$35K |
|